TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies

April 19, 2022 8:36 AM EDT

Jefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while maintaining a Buy rating.

The analyst commented, "During Monday morning's press conference TG announced it's pausing its oncology programs. The decision was made based on updated... More